Free Trial

CorVel (CRVL) Competitors

CorVel logo
$350.29 -15.97 (-4.36%)
(As of 12/17/2024 ET)

CRVL vs. LH, DGX, DVA, CHE, RCM, AMED, MD, AMN, CCRN, and ERIE

Should you be buying CorVel stock or one of its competitors? The main competitors of CorVel include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), R1 RCM (RCM), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), and Erie Indemnity (ERIE).

CorVel vs.

CorVel (NASDAQ:CRVL) and Laboratory Co. of America (NYSE:LH) are both business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, community ranking, media sentiment and valuation.

Laboratory Co. of America has higher revenue and earnings than CorVel. Laboratory Co. of America is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CorVel$845.64M7.09$76.25M$4.7174.37
Laboratory Co. of America$12.71B1.52$418M$5.1744.67

Laboratory Co. of America received 427 more outperform votes than CorVel when rated by MarketBeat users. Likewise, 64.04% of users gave Laboratory Co. of America an outperform vote while only 63.88% of users gave CorVel an outperform vote.

CompanyUnderperformOutperform
CorVelOutperform Votes
191
63.88%
Underperform Votes
108
36.12%
Laboratory Co. of AmericaOutperform Votes
618
64.04%
Underperform Votes
347
35.96%

In the previous week, Laboratory Co. of America had 9 more articles in the media than CorVel. MarketBeat recorded 18 mentions for Laboratory Co. of America and 9 mentions for CorVel. CorVel's average media sentiment score of 1.35 beat Laboratory Co. of America's score of 1.21 indicating that CorVel is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CorVel
4 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Laboratory Co. of America
13 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

CorVel has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Comparatively, Laboratory Co. of America has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500.

Laboratory Co. of America has a consensus price target of $258.62, indicating a potential upside of 11.98%. Given Laboratory Co. of America's stronger consensus rating and higher probable upside, analysts plainly believe Laboratory Co. of America is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CorVel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Laboratory Co. of America
0 Sell rating(s)
4 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.81

CorVel has a net margin of 9.64% compared to Laboratory Co. of America's net margin of 3.43%. CorVel's return on equity of 31.73% beat Laboratory Co. of America's return on equity.

Company Net Margins Return on Equity Return on Assets
CorVel9.64% 31.73% 17.12%
Laboratory Co. of America 3.43%15.27%7.13%

51.4% of CorVel shares are held by institutional investors. Comparatively, 95.9% of Laboratory Co. of America shares are held by institutional investors. 47.6% of CorVel shares are held by company insiders. Comparatively, 0.9% of Laboratory Co. of America shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Laboratory Co. of America beats CorVel on 11 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRVL vs. The Competition

MetricCorVelInsurance agents, brokers, & service IndustryBusiness SectorNASDAQ Exchange
Market Cap$6.00B$17.82B$6.83B$9.31B
Dividend YieldN/A3.05%2.96%4.06%
P/E Ratio74.3727.5945.8517.54
Price / Sales7.097.54485.99140.34
Price / Cash59.7631.7829.1437.95
Price / Book24.1916.385.664.92
Net Income$76.25M$830.46M$125.22M$225.78M
7 Day Performance-2.21%-1.24%2.32%-1.58%
1 Month Performance-1.60%-0.02%8.89%6.67%
1 Year Performance48.80%10.20%30.27%22.48%

CorVel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRVL
CorVel
1.2715 of 5 stars
$350.29
-4.4%
N/A+49.9%$6.00B$845.64M74.374,870Stock Split
Positive News
LH
Laboratory Co. of America
4.9744 of 5 stars
$230.38
-0.7%
$257.67
+11.8%
+5.2%$19.27B$12.71B44.8867,000Analyst Forecast
Positive News
DGX
Quest Diagnostics
4.8497 of 5 stars
$152.89
-1.4%
$168.92
+10.5%
+15.2%$17.06B$9.54B20.8348,000Analyst Upgrade
DVA
DaVita
4.3425 of 5 stars
$150.76
-1.3%
$161.80
+7.3%
+39.6%$12.36B$12.14B16.4870,000Positive News
CHE
Chemed
4.9328 of 5 stars
$542.93
-0.7%
$641.50
+18.2%
-8.6%$8.17B$2.38B27.6415,087Short Interest ↓
Positive News
RCM
R1 RCM
1.0865 of 5 stars
$14.31
+0.1%
$15.73
+9.9%
+36.8%$6.04B$2.25B-95.3930,000High Trading Volume
AMED
Amedisys
4.0194 of 5 stars
$85.69
+0.0%
$100.67
+17.5%
-9.7%$2.81B$2.32B33.9719,000
MD
Pediatrix Medical Group
3.3788 of 5 stars
$14.58
+3.6%
$16.42
+12.6%
+57.5%$1.25B$1.99B-4.605,170Analyst Forecast
AMN
AMN Healthcare Services
4.8594 of 5 stars
$25.43
-5.9%
$48.33
+90.1%
-65.1%$968.22M$3.07B19.583,585Short Interest ↓
CCRN
Cross Country Healthcare
2.888 of 5 stars
$17.94
-0.7%
$18.54
+3.3%
-14.6%$590.53M$1.45B-359.4010,831Short Interest ↓
ERIE
Erie Indemnity
2.6583 of 5 stars
$423.53
+0.7%
N/A+30.9%$19.56B$3.82B39.366,556Dividend Increase
News Coverage

Related Companies and Tools


This page (NASDAQ:CRVL) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners